Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

ENENGN
1 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in ENGENE THERAPEUTICS INC COM

Yes. Wells Fargo holds 6,840 shares of ENGN (Engene Therapeutics), worth $11,833, as of its Q2 2026 13F filing.

Current Value

$11,833

Current Shares

6,840

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
6,840
-
$11,8330.0%$1.73
27

Other major holders of ENGN: AMERIPRISE FINANCIAL INC, MARSHALL WACE, LLP, BALYASNY ASSET MANAGEMENT L.P., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used